These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38864518)

  • 1. The Sexual Health Clinic Role in Vaccine and Treatment Access During the 2022 Mpox Outbreak in King County, Washington.
    Karmarkar EN; Cannon CA; Golden MR; Thibault CS; Zinsli K; Kim J; Pogosjans S; Chow EJ; Herrmann SO; Ocbamichael N; Ramchandani MS; Dombrowski JC
    Sex Transm Dis; 2024 Jun; ():. PubMed ID: 38864518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Diagnosis Is Highly Predictive of Laboratory-Confirmed Mpox in a Sexual Health Clinic.
    Cannon CA; Karmarkar EN; Ramchandani MS; Dombrowski JC; Golden MR
    Sex Transm Dis; 2024 May; 51(5):348-351. PubMed ID: 38346404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Tecovirimat Therapy With Mpox Symptom Improvement: A Cross-sectional Study-King County, Washington, May-October 2022.
    Karmarkar EN; Golden MR; Kerani RP; Pogosjans S; Chow EJ; Bender Ignacio RA; Ramchandani MS; Kay MK; Cannon CA; Dombrowski JC
    Open Forum Infect Dis; 2024 Mar; 11(3):ofae029. PubMed ID: 38456195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Addressing mpox at a Frontline Community Health Center: Lessons for the Next Outbreak.
    Allan-Blitz LT; Khan T; Elangovan K; Smith K; Multani A; Mayer KH
    Public Health Rep; 2024; 139(3):294-300. PubMed ID: 37846528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early Tecovirimat Treatment for Mpox Disease Among People With HIV.
    Aldred B; Lyles RH; Scott JY; Gromer DJ; Aldredge A; Workowski KA; Wiley Z; Titanji BK; Szabo B; Sheth AN; Rebolledo PA; Nguyen ML; Marconi VC; Kelley CF; Kandiah S; Kalapila A; Jacob JT; Hall B; Colasanti JA; Cartwright EJ; Cantos VD
    JAMA Intern Med; 2024 Mar; 184(3):275-279. PubMed ID: 38190312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful Distribution of Tecovirimat During the Peak of the Mpox Outbreak - Los Angeles County, June 2022-January 2023.
    O'Neil MJ; Archer R; Danza P; Fisher R; Bagwell DA; Younis I; Kulkarni S; Rubin Z; Kim M; Balter S; Terashita D; Kim J; Singhal R; Hancz D; Gausche-Hill M; Shah NK
    MMWR Morb Mortal Wkly Rep; 2024 Jun; 73(24):546-550. PubMed ID: 38900699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mpox in people with past infection or a complete vaccination course: a global case series.
    Hazra A; Zucker J; Bell E; Flores J; Gordon L; Mitjà O; Suñer C; Lemaignen A; Jamard S; Nozza S; Nori AV; Pérez-Barragán E; Rodríguez-Aldama JC; Blanco JL; Delaugerre C; Turner D; Fuertes I; Leiro V; Walmsley SL; Orkin CM;
    Lancet Infect Dis; 2024 Jan; 24(1):57-64. PubMed ID: 37678309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disparities in Mpox Vaccination Among Priority Populations During the 2022 Outbreak.
    Alavian N; Mourad A; Woodhouse EW; Niehaus E; Cunningham H; Zavala S; Kohler P; Pappas S; Yarrington ME; Okeke NL; Wolfe CR; Cox GM; Dicks KV; Stout JE
    Open Forum Infect Dis; 2023 Sep; 10(9):ofad434. PubMed ID: 37662451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of the Modified Vaccinia Ankara Vaccine Against Mpox in Men Who Have Sex With Men: A Retrospective Cohort Analysis, Seattle, Washington.
    Ramchandani MS; Berzkalns A; Cannon CA; Dombrowski JC; Brown E; Chow EJ; Barash E; Pogosjans S; Smith D; Golden MR
    Open Forum Infect Dis; 2023 Nov; 10(11):ofad528. PubMed ID: 37942460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mpox Vaccine Interest Survey Prioritization and Data Flow: Maricopa County, Arizona, July-August 2022.
    Howard BJ; Collins JE; Staab RN; Singh S; Lara E; Kretschmer M; Rehder L; Dellos A; White JR; Dale AP
    Am J Public Health; 2023 May; 113(5):504-508. PubMed ID: 36893362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mpox vaccination willingness, determinants, and communication needs in gay, bisexual, and other men who have sex with men, in the context of limited vaccine availability in the Netherlands (Dutch Mpox-survey).
    Dukers-Muijrers NHTM; Evers Y; Widdershoven V; Davidovich U; Adam PCG; Op de Coul ELM; Zantkuijl P; Matser A; Prins M; de Vries HJC; den Heijer C; Hoebe CJPA; Niekamp AM; Schneider F; Reyes-Urueña J; Croci R; D'Ambrosio A; van der Valk M; Posthouwer D; Ackens R; Ter Waarbeek H; Noori T; Hoornenborg E
    Front Public Health; 2022; 10():1058807. PubMed ID: 36684959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modifications to Sexual Behaviors Associated With Mpox (Monkeypox) Virus Transmission Among Persons Presenting for mpox Vaccination, Washington, DC, August-October, 2022.
    Copen CE; Delaney KP; Agnew-Brune C; Berry I; Griffin I; Hassan R; Oakley LP; Wondmeneh S; Rhodes T; Gillani S; Lee M; Ashley P; Willut C; Mangla AT; Waltenburg MA; Jackson DA;
    Sex Transm Dis; 2024 Jan; 51(1):54-60. PubMed ID: 37889944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of JYNNEOS Vaccine Against Diagnosed Mpox Infection - New York, 2022.
    Rosenberg ES; Dorabawila V; Hart-Malloy R; Anderson BJ; Miranda W; O'Donnell T; Gonzalez CJ; Abrego M; DelBarba C; Tice CJ; McGarry C; Mitchell EC; Boulais M; Backenson B; Kharfen M; McDonald J; Bauer UE
    MMWR Morb Mortal Wkly Rep; 2023 May; 72(20):559-563. PubMed ID: 37339074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding the Impact of Mpox on Sexual Health Clinical Services: A National Knowledge, Attitudes, and Practices Survey-United States, 2022.
    Schubert SL; Miele K; Quilter LAS; Agnew-Brune C; Coor A; Kachur R; Lewis F; Ard KL; Wendel K; Anderson T; Nagendra G; Tromble E;
    Sex Transm Dis; 2024 Jan; 51(1):38-46. PubMed ID: 37889929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging pharmacological strategies for treating and preventing mpox.
    Grosenbach DW; Russo AT; Blum ED; Hruby DE
    Expert Rev Clin Pharmacol; 2023; 16(9):843-854. PubMed ID: 37592723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful Outcome after Treatment with Cidofovir, Vaccinia, and Extended Course of Tecovirimat in a Newly-Diagnosed HIV Patient with Severe Mpox: A Case Report.
    Martinez AE; Frattaroli P; Vu CA; Paniagua L; Mintz J; Bravo-Gonzalez A; Zamudio P; Barco A; Rampersad A; Lichtenberger P; Gonzales-Zamora JA
    Vaccines (Basel); 2023 Mar; 11(3):. PubMed ID: 36992234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sexual and Gender Minorities' Vaccine Uptake and Behavioral Change in Response to the Mpox Outbreak in the United States: August 2022 Through November 2022.
    Grov C; Zohra F; Mirzayi C; Stief M; D'Angelo AB; Dearolf M; Westmoreland DA; Carneiro P; Nash D; Carrico AW
    Clin Infect Dis; 2024 Jan; ():. PubMed ID: 38262167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tecovirimat for the treatment of severe Mpox in Germany.
    Hermanussen L; Brehm TT; Wolf T; Boesecke C; Schlabe S; Borgans F; Monin MB; Jensen BO; Windhaber S; Scholten S; Jordan S; Lütgehetmann M; Wiesch JSZ; Addo MM; Mikolajewska A; Niebank M; Schmiedel S
    Infection; 2023 Oct; 51(5):1563-1568. PubMed ID: 37273167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutics for treating mpox in humans.
    Fox T; Gould S; Princy N; Rowland T; Lutje V; Kuehn R
    Cochrane Database Syst Rev; 2023 Mar; 3(3):CD015769. PubMed ID: 36916727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mpox Case Reports in an Urban Homeless Population and a Proof of Concept for a Street-Based Mobile Mpox Vaccination Clinic.
    Zeien J; Vieira J; Hanna J; Surendra L; Stenzel J; Ramirez A; Miller C; Rosales C
    J Prim Care Community Health; 2023; 14():21501319231169991. PubMed ID: 37191007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.